Ocular Microphysiological Systems for Glaucoma Drug Development
A Human-Relevant Platform for Studying Aqueous Outflow, Evaluating Therapeutic Interventions, and Advancing Ophthalmic Drug Development U.S. Patent No. 12,681,004 B1 Advancing Glaucoma Research Through Organ-on-a-Chip Technology Glaucoma is a leading cause of irreversible vision loss and is frequently associated with … Read More